Physician profile
David Brogno
NPI 1457373656
$3,246.80
in general payments reported to CMS, 2019-2025
15 companies · $794 in 2025
The $794 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $229 · 2021: $288 · 2022: $450 · 2023: $345 · 2024: $774 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,912.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $667.73 | 2019-2024 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $445.50 | 2019-2023 | Pressurewire |
| Boston Scientific Corporation | $375.12 | 2020-2025 | Watchman Flx, General - Vascular Access |
| Terumo Medical Corporation | $353.06 | 2021-2025 | Angio-Seal, Glidesheath Slender, Heartrail |
| Asahi Intecc USA, INC. | $249.98 | 2022-2025 | Asahi Coronary Wires |
| Abiomed | $209.98 | 2024-2025 | Impella |
| Heartflow, INC. | $195.44 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $171.16 | 2024 | Optimizer |
| Arrow International, INC. | $144.85 | 2019 | |
| Philips North America LLC | $127.28 | 2022-2024 | (Bq9) Coronary Ivus |
| Cordis US Corp. | $111.11 | 2025 | Mynx Control Venous |
| Astrazeneca Pharmaceuticals Lp | $88.60 | 2020 | |
| W. L. Gore & Associates, INC. | $44.12 | 2024 | Gore Cardioform Septal Occluder |
| E.R. Squibb & Sons, L.L.C. | $37.87 | 2022 | |
| Novo Nordisk INC | $25.00 | 2023 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brogno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.